GABELLI FUNDS LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 149 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$5,099,000
+32.6%
118,000
+29.7%
0.03%
+50.0%
Q2 2015$3,846,000
+9.0%
91,0000.0%0.02%
+11.1%
Q1 2015$3,529,000
+15.2%
91,0000.0%0.02%
+20.0%
Q4 2014$3,064,000
-1.7%
91,000
+2.2%
0.02%
-6.2%
Q3 2014$3,117,000
+10.3%
89,000
+3.5%
0.02%
+14.3%
Q2 2014$2,826,000
-10.9%
86,0000.0%0.01%
-12.5%
Q1 2014$3,170,000
-12.1%
86,000
-8.5%
0.02%
-15.8%
Q4 2013$3,608,000
-21.9%
94,000
-44.2%
0.02%
-26.9%
Q3 2013$4,617,000
-20.8%
168,500
-39.3%
0.03%
-25.7%
Q2 2013$5,831,000277,6480.04%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 261,361$8,588,0006.86%
Black Creek Investment Management Inc. 1,644,485$54,038,0005.68%
Consonance Capital Management LP 1,143,315$37,569,0005.59%
Sloane Robinson LLP 120,000$3,943,0002.47%
THOMAS WHITE INTERNATIONAL LTD 470,769$15,469,0002.16%
Grandeur Peak Global Advisors, LLC 295,035$9,695,0002.09%
Mirae Asset Global Investments Co., Ltd. 2,370,406$77,891,0001.73%
Granite Point Capital Management, L.P. 70,000$2,300,0001.58%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 89,810$2,951,0001.38%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$86,315,0001.16%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders